Scientific Session
Systemic lupus erythematosus (SLE)
J. Michelle Kahlenberg, MD, PhD
University of Michigan
Ann Arbor, MI, United States
Disclosure: Disclosure(s): Ample Biosolutions: Advisor or Review Panel Member (Ongoing); AstraZeneca: Consultant (Ongoing); Aurinia Pharmaceuticals: Advisor or Review Panel Member (Ongoing); Bristol-Myers Squibb(BMS): Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); EMD-Serano: Consultant (Ongoing); Gilead: Consultant (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Horizon Therapeutics: Consultant (Ongoing); Q 32 Bio: Grant/Research Support (Terminated); Rome Therapeutics: Grant/Research Support (Ongoing); Ventus Therapeutics: Consultant (Ongoing), Grant/Research Support (Ongoing)